OWC Pharmaceutical Research Corp. announced that it has appointed Ms. Sigal Russo as Chief Financial Officer of the company. Sigal Russo will replace Yossi Dagan who resigned as Chief Financial Officer of the Company on February 1, 2019, effective immediately. Most recently, Ms. Russo served as Senior Director of Finance of Rosetta Genomics Ltd.